Lorenzo
Redondo Collazo
![Foto de Lorenzo](/img/nophoto.png)
![Foto de Harvard Medical School](/img/noimage_org.png)
Harvard Medical School
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Harvard Medical School (1)
2022
-
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome
Journal of Neurodevelopmental Disorders, Vol. 14, Núm. 1